All positions are filled for the grant cycle.
NEPTUNE provides a unique opportunity for training scientists dedicated to studying glomerular disease. Due to insufficient opportunity in the past, few potential investigators were drawn to this area. NEPTUNE helped to transformed this environment by assembling a talented community of scientists with diverse backgrounds, by collecting unique resources, and by uncovering outstanding research opportunities that can be exploited to expand the pool of scientists who employ modern experimental approaches for work in glomerular diseases.
The NEPTUNE training program is designed for advanced post-doctoral and junior faculty trainees, or established investigators interested in redirecting their investigative focus, who are preparing to become independent investigators in clinical and translational research in human glomerular disease. Key components of the NEPTUNE training program include: a) a mentored research project, b) an individualized training program with formal didactic training, c) associated career development activities, d) training in responsible conduct of research, e) subsequent research experiences. NEPTUNE trainees are actively engaged in focused working groups, committees and meeting presentations.
The program has spanned 6 years, with over 30 applications and nine selected trainees who have completed the program. Dr Larry Holzman provides leadership for the program. The NEPTUNE fellows are:
- Hani Suleiman, MD, PhD, Washington University in St Louis, “Sarcomere-Like Structures” as an indicator for podocyte injury in nephrotic syndrome
- Debora Malta C.s. Santos, PhD, University of Pittsburg, The role of the miR-17~92 microRNA cluster in glomerulopathies
- Jarcy Zee, PhD, Arbor Research Collaborative, Statistical Methods for Analysis of Glomerular Disease Morphology Data
- Ying M. Chen, MD, PhD, Washington University in St Louis, Podocyte Endoplasmic Reticulum Stress and Focal Segmental Glomerulosclerosis
- Larysa Wickman, MD, University of Michigan, Urinary podocyte-specific mRNA ratio as a marker of glomerular disease
- Pietro Canetta, MD, Columbia University, Genetic risks for common mechanisms of injury among distinct nephrotic diseases
- Rivka Ayalon, MD, Boston University, The value of anti-PLA2R for diagnosis and monitoring of membranous nephropathy
- Tanya Pereira, MD, University of Miami, Role of soluble urokinase (suPAR) in early onset Nephrotic Syndrome
- Vimal Derebail, MD, MPH, University of North Carolina, A novel mechanism for venous thromboembolism in nephrotic syndrome